# reload+after+2024-01-20 07:45:19.990051
address1§1100 Campus Road
city§Princeton
state§NJ
zip§08540
country§United States
phone§609 275 0500
fax§609 750 4277
website§https://www.integralife.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
fullTimeEmployees§3722
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Jan  De Witte', 'age': 59, 'title': 'President, CEO & Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 1819806, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Eric Ian Schwartz', 'age': 54, 'title': 'Executive VP, Chief Legal Officer & Secretary', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 847200, 'exercisedValue': 0, 'unexercisedValue': 92281}, {'maxAge': 1, 'name': 'Mr. Robert T. Davis Jr.', 'age': 64, 'title': 'Executive VP & President of Tissue Technologies', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 781230, 'exercisedValue': 0, 'unexercisedValue': 796981}, {'maxAge': 1, 'name': 'Mr. Michael J. McBreen', 'age': 57, 'title': 'Executive VP & President of Codman Specialty Surgical', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 780769, 'exercisedValue': 0, 'unexercisedValue': 62644}, {'maxAge': 1, 'name': 'Ms. Lea Daniels Knight', 'title': 'Executive VP & CFO', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Stephen  Leonard', 'age': 61, 'title': 'Corporate Vice President of Global Operations & Supply Chain', 'yearBorn': 1962, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeffrey A. Mosebrook', 'age': 47, 'title': 'Senior VP & PAO', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mathieu  Aussermeier', 'title': 'Vice President of Corporate Finance, Investor Relations & Treasurer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. William  Compton', 'title': 'Chief Information Officer & Corporate VP', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Laurene  Isip', 'title': 'Vice President of Global Corporate Communications & Public Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§1
boardRisk§4
compensationRisk§2
shareHolderRightsRisk§1
overallRisk§1
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.166
priceToSalesTrailing12Months§2.1315753
currency§USD
dateShortInterest§1702598400
forwardEps§3.44
pegRatio§3.7
exchange§NMS
quoteType§EQUITY
shortName§Integra LifeSciences Holdings C
longName§Integra LifeSciences Holdings Corporation
firstTradeDateEpochUtc§808579800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§069a3d6c-47d3-32ea-be52-b6fb5f53417c
gmtOffSetMilliseconds§-18000000
targetHighPrice§57.0
targetLowPrice§37.0
targetMeanPrice§46.1
targetMedianPrice§47.5
recommendationMean§2.9
recommendationKey§hold
numberOfAnalystOpinions§10
quickRatio§1.575
earningsGrowth§-0.6
grossMargins§0.62016
ebitdaMargins§0.25118
trailingPegRatio§1.0219
